Abstract: Today's mobile applications oftentimes need to detect user-defined complex patterns (e.g., the mysterious “phantom traffic jam”) over data streams to support decision making. It is achieved ...

QUZHOU, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- In the complex architecture of the global energy ...

Order doesn’t always form perfectly—and those imperfections can be surprisingly powerful. In materials like liquid crystals, tiny “defects” emerge when symmetry breaks, shaping everything from cosmic ...

Further Israeli troop withdrawals in Gaza tied to Hamas giving up weapons US and Trump's Board of Peace to pressure Hamas to disarm Palestinian militant group says it has not seen detailed or concrete ...

The city of Macomb will wait for a state bond program to open and award projects before deciding whether to move ahead on development of an indoor sports complex. “Right now, we have a substantial ...

Don't miss the big stories. Like us on Facebook. BELLOWS FALLS — On Saturday, Feb. 7, the public is invited to the Rockingham Free Public Library for a presentation sponsored by Vermont Humanities ...

Add Yahoo as a preferred source to see more of our stories on Google. PENNSYLVANIA (WTAJ) — The Pennsylvania Medical Marijuana program has seen a decline in enrollment over the past year, which could ...

[1] Plans to develop Albuquerque westside apartment complex move forward – An area in Albuquerque’s west side has been the subject of debate as community and tribal members have argued against the ...

PITTSBURGH — Highmark awarded a $1 million grant to South Side-based Achieva to build a home transition program for children with complex medical needs. The grant will bolster the Beyond Boundaries ...

Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial planned to start in the first quarter of 2026 Jay Hagan joins as Chief Executive Officer ...

The MarketWatch News Department was not involved in the creation of this content. -- Neridronate granted FDA Breakthrough Therapy, Fast-Track, and Orphan Drug designations; pivotal Phase 3 trial ...